Description
Endogenous Copper Tripeptide Research Compound
GHK-Cu is a naturally occurring copper tripeptide whose endogenous concentration declines with age — from approximately 200 ng/mL in plasma at age 20 to ~80 ng/mL at 60. This decline is studied in the context of reduced skin thickness, elasticity, and tissue repair capacity. GHK-Cu has one of the broadest activity profiles in the dermal-research literature: collagen synthesis, wound healing, inflammatory signalling, and gene-expression modulation in ageing tissue.
It is the same compound used in cosmetic serums at low topical concentrations. Research-grade lyophilized peptide is supplied for protocols requiring controlled, larger-quantity laboratory study.
Key Research Areas
- Collagen & Elastin Synthesis — Studied for stimulating structural protein production in dermal fibroblasts
- Wound Healing — Studied across multiple wound healing models for accelerated epidermal repair
- Dermal Gene Expression — Studied for influence on >4,000 human genes, including repair, renewal, and inflammation pathways
- Inflammation Modulation — Studied for reducing chronic low-grade dermal inflammation
Research Disclaimer
Pioneer Research products are supplied exclusively for legitimate scientific and laboratory research purposes. They are not sold, represented or supplied for human or veterinary use, consumption, diagnosis, treatment, prevention or modification of any disease or condition.
By purchasing, you acknowledge that you are acquiring these materials solely for legitimate research purposes and agree not to use them in humans or animals.
Pioneer Research does not provide medical advice, dosing instructions or guidance for human or veterinary use.
Lab Testing
Every batch of GHK-cu is independently tested by Janoshik Analytical to verify identity, purity and composition.
Test results are documented at the batch level, providing researchers with transparent analytical data and confidence in the material supplied.